ENvue Medical (FEED) Profit After Tax Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.39% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 3.79% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 30.83% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 60.12% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.38% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 6.53% |
| 10 | ENvue Medical | 2.97 Mn | 709,615.89 | -55,000.00 | -51.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.60% |
| Dec 31, 2025 | -84.12% |
| Sep 30, 2025 | 36.33% |
| Jun 30, 2025 | -45.02% |
| Mar 31, 2025 | -30.14% |
| Dec 31, 2024 | 16.68% |
| Sep 30, 2024 | 46.92% |
| Jun 30, 2024 | -47.13% |
| Mar 31, 2024 | 50.73% |
| Dec 31, 2023 | 6.85% |
| Sep 30, 2023 | 7.62% |
| Jun 30, 2023 | 10.08% |
| Mar 31, 2023 | -6.00% |
| Dec 31, 2022 | -19.95% |
| Sep 30, 2022 | -5.43% |
| Jun 30, 2022 | -5.56% |
| Mar 31, 2022 | 24.96% |
| Dec 31, 2021 | -27.38% |
| Sep 30, 2021 | -70.62% |
| Jun 30, 2021 | 36.00% |
| Mar 31, 2021 | -84.02% |
| Dec 31, 2020 | 15.05% |
| Sep 30, 2020 | 16.77% |
| Jun 30, 2020 | -20.27% |
| Mar 31, 2020 | -1.65% |
| Dec 31, 2019 | -2.13% |
| Sep 30, 2019 | -10.38% |
| Jun 30, 2019 | -21.98% |
| Mar 31, 2019 | -75.57% |
| Dec 31, 2018 | -15.30% |
| Sep 30, 2018 | -8.96% |
| Jun 30, 2018 | -23.83% |
| Mar 31, 2018 | -7.79% |
| Dec 31, 2017 | -27.06% |
| Sep 30, 2017 | -27.80% |
| Jun 30, 2017 | -13.67% |
| Mar 31, 2017 | -20.36% |